Westside Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57K | Buy |
805
+455
| +130% | +$32.2K | 0.01% | 438 |
|
|
2025
Q1 | $25.7K | Hold |
350
| – | – | 0.01% | 517 |
|
|
2024
Q4 | $22.9K | Buy |
350
+50
| +17% | +$3.28K | ﹤0.01% | 537 |
|
|
2024
Q3 | $23.4K | Hold |
300
| – | – | 0.01% | 544 |
|
|
2024
Q2 | $23.4K | Hold |
300
| – | – | 0.01% | 516 |
|
|
2024
Q1 | $20.3K | Hold |
300
| – | – | ﹤0.01% | 516 |
|
|
2023
Q4 | $20.2K | Hold |
300
| – | – | 0.01% | 497 |
|
|
2023
Q3 | $20.3K | Sell |
300
-297
| -50% | -$20.1K | 0.01% | 483 |
|
|
2023
Q2 | $42.7K | Hold |
597
| – | – | 0.01% | 375 |
|
|
2023
Q1 | $41.4K | Hold |
597
| – | – | 0.01% | 379 |
|
|
2022
Q4 | $40 | Hold |
597
| – | – | ﹤0.01% | 436 |
|
|
2022
Q3 | $32 | Sell |
597
-100
| -14% | -$5 | ﹤0.01% | 451 |
|
|
2022
Q2 | $46 | Sell |
697
-100
| -13% | -$7 | ﹤0.01% | 411 |
|
|
2022
Q1 | $52 | Sell |
797
-403
| -34% | -$26 | ﹤0.01% | 412 |
|
|
2021
Q4 | $69 | Sell |
1,200
-5,883
| -83% | -$338 | ﹤0.01% | 379 |
|
|
2021
Q3 | $425 | Buy |
7,083
+1,498
| +27% | +$90 | ﹤0.01% | 279 |
|
|
2021
Q2 | $334 | Buy |
5,585
+550
| +11% | +$33 | ﹤0.01% | 279 |
|
|
2021
Q1 | $250 | Buy |
5,035
+3,635
| +260% | +$180 | ﹤0.01% | 282 |
|
|
2020
Q4 | $30K | Buy |
1,400
+300
| +27% | +$6.44K | 0.08% | 117 |
|
|
2020
Q3 | $32.9K | Buy |
1,100
+600
| +120% | +$17.9K | 0.02% | 107 |
|
|
2020
Q2 | $26 | Buy |
+500
| New | +$26 | ﹤0.01% | 374 |
|